10-Q · May 11, 2026
Microvast Holdings, Inc. reported a significant revenue decline of 48.0% year-over-year, falling to $60.6 million in Q1 2026 primarily driven by reduced sales volume and heightened regulatory challenges, while operating…
Earnings analysis · 10-Q
Filed August 10, 2026 · Our reading of the company's report
The latest report
Microvast's Q2 revenue of $87.262 million recovered sequentially from $61 million but remained below the $91 million reported in Q2 2025 and missed the $94.102 million consensus estimate. EPS of negative $0.01 was…
Microvast's Q2 revenue of $87.262 million recovered sequentially from $61 million but remained below the $91 million reported in Q2 2025 and missed the $94.102 million consensus estimate. EPS of negative $0.01 was better than the prior-year loss but missed the $0.01 estimate. The filing highlights severe liquidity pressure, including $33.3 million of six-month operating cash burn, $104.2 million of near-term borrowings, restricted overseas cash, and continuing substantial doubt about the company's ability to continue as a going concern.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Q2 revenue was $87.262 million, up approximately 43% from $61 million in Q1 2026 but down approximately 4% from $91 million in Q2 2025. Reported EPS was negative $0.01 versus negative $0.04 in Q1 2026 and negative $0.33 in the prior-year quarter.
For the six months ended June 30, 2026, the company used $33.3 million of operating cash flow versus $44.3 million generated in the prior-year period. Management attributed the deterioration partly to a 28.8% revenue decline and gross margin compression from 36.0% to 30.4%.
Cash and cash equivalents totaled $127.8 million at June 30, 2026, but $39.7 million held by Chinese subsidiaries and $23.5 million held by European subsidiaries could not currently be repatriated to fund U.S. operations or the Clarksville expansion.
Management reported that disclosure controls were effective as of June 30, 2026, and stated that there were no changes in internal control over financial reporting that materially affected, or were reasonably likely to materially affect, controls during the quarter.
The company reaffirmed substantial doubt about going-concern status. It reported an accumulated deficit of $1,086.0 million, used $33.3 million in operating cash during the first six months of 2026, and had $104.2 million of $118.6 million in borrowings due within the next 12 months.
Near-term refinancing requirements are substantial: the company had $118.6 million of bank borrowings, $41.7 million of bonds payable repayable on or before January 31, 2027, and $37.5 million of outstanding purchase commitments. Management stated its refinancing plan cannot be deemed probable.
The company disclosed potential Nasdaq minimum-bid-price noncompliance, stating its closing bid price had been below $1.00 per share beginning July 13, 2026. A delisting could impair trading liquidity and access to financing.
No quantitative revenue or EPS guidance was provided in the extracted 10-Q. Management's liquidity plans include cost reductions, discretionary capex deferrals, debt refinancing or extensions, and evaluation of additional financing alternatives.
Microvast Holdings, Inc. reported a significant revenue decline of 48.0% year-over-year, falling to $60.6 million in Q1 2026 primarily driven by reduced sales volume and heightened regulatory challenges, while operating…
Microvast Holdings, Inc. reported a 12.6% year-over-year revenue increase, reaching a record $427.5 million for the fiscal year ended December 31, 2025, despite a significant net loss of $29.2 million. The company faced…
Microvast Holdings, Inc. reported a strong third quarter with revenues of $123.3 million, representing a 21.6% growth year-over-year. However, diluted EPS was reported at $0.04, slightly missing estimates. Management…
Microvast Holdings, Inc. reported quarterly results for Q2 2025 showing a 9.2% increase in revenue year-over-year to $91.3 million, driven by a notable sales volume increase. Despite an earnings surprise with EPS of…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.